114 related articles for article (PubMed ID: 11932917)
21. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
Fadare O
Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
[TBL] [Abstract][Full Text] [Related]
22. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant.
Fujiwara M; Horiguchi M; Mori S; Yokoyama K; Horiguchi H; Fukazawa M; Fujiwara H; Yano Y; Satoh H; Kamma H
Pathol Int; 2005 Jun; 55(6):353-9. PubMed ID: 15943793
[TBL] [Abstract][Full Text] [Related]
23. Pure or mixed-type invasive lobular carcinoma?
Bulut N; Dede DS; Sari E; Altundag K
Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
[No Abstract] [Full Text] [Related]
24. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
25. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma.
Sentani K; Tashiro T; Oue N; Yasui W
APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414
[No Abstract] [Full Text] [Related]
26. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
27. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
[TBL] [Abstract][Full Text] [Related]
28. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
31. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
33. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
[TBL] [Abstract][Full Text] [Related]
34. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma.
Rosen PP
Am J Surg Pathol; 1999 Dec; 23(12):1561. PubMed ID: 10584711
[No Abstract] [Full Text] [Related]
35. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
[TBL] [Abstract][Full Text] [Related]
36. In situ and invasive lobular neoplasia of the breast.
Hanby AM; Hughes TA
Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
[TBL] [Abstract][Full Text] [Related]
37. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
38. [Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer].
García Tamayo J; Blasco Olaetxea E; Morales A; Molina J; Guzmán Bistoni C; Méndez V
Invest Clin; 2006 Dec; 47(4):371-83. PubMed ID: 17176905
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
40. Lobular carcinoma in situ of the breast and ductoscopy.
Gur AS; Unal B; Zhao C; Johnson R; Edington H; Soran A
Breast J; 2010; 16(3):318-20. PubMed ID: 20408824
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
